|
China's healthcare reforms generate uncertainty for its domestic pharmaceutical market. Part of a special outsourcing section.
Feb 23, 2012
By:
Jon Zifferblatt
China's healthcare reforms are generating uncertainty for its domestic pharmaceutical market, writes Jon Zifferblatt.
|
Jun 1, 2011
By:
Jon Zifferblatt
Foreign investors need the wiles of a tigress as the government revisits the idea of private healthcare
|
|
If there is one market this year that requires a click on the refresh button, it's China. If the 'growth curve' key was pressed, it should be your first delete. Pharm Exec's local partner, General Biologic, logs on with a snapshot of what's ahead for Big Pharma in managing for long-term success
Feb 1, 2011
By:
Jon Zifferblatt
If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshhot of what's ahead for Big Pharma in the country
|
|
Nov 1, 2010
By:
Jon Zifferblatt
A shakeout is ahead as China restructures its murky and insular system of drug distribution
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
